Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia

Tan, Shi; Zhang, Ling; Zhong, Xiao-Ming; Yang, Zai-Lin; Zhao, Liu-Yang; Gao, Yu-Jie; Shao, Hui-Yuan; Qin, Feng-Xian; Chen, Xian-Chun; Zhang, Hui-Juan; Chen, Hui; Wang, Li

doi:10.7150/ijms.8.309



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2011; 8(4):309-314. doi:10.7150/ijms.8.309 This issue Cite

Research Paper

Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia

Shi Tan¹, Ling Zhang^1✉, Xiao-Ming Zhong¹, Zai-Lin Yang², Liu-Yang Zhao¹, Yu-Jie Gao¹, Hui-Yuan Shao¹, Feng-Xian Qin¹, Xian-Chun Chen¹, Hui-Juan Zhang¹, Hui Chen³, Li Wang⁴

1. Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China
2. Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing 400016, China
3. Department of Laboratory Medicine, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China
4. Department of Hematology, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China

Citation:

Tan S, Zhang L, Zhong XM, Yang ZL, Zhao LY, Gao YJ, Shao HY, Qin FX, Chen XC, Zhang HJ, Chen H, Wang L. Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia. Int J Med Sci 2011; 8(4):309-314. doi:10.7150/ijms.8.309. https://www.medsci.org/v08p0309.htm

Other styles

Abstract

Nucleophosmin (NPM1) gene mutations resulting in cytoplasmic delocalization of Nucleophosmin (NPMc+) are the most common genetic alteration in acute myeloid leukemia (AML). Here, we attempted to prepare monoclonal antibodies (mAbs) against NPM1 mutation A (NPM-mA) and investigated the mAbs' clinical utility in immunohistochemical detection of NPMc+AML. The pET-32a-NPM-mA vector with the whole open reading frame of the NPM-mA gene was constructed. E.coli BL21 transformed with the vector were induced to express the NPM-mA recombinant protein. BALB/c mice were immunized with the recombinant NPM-mA. Positive clones were selected by indirect ELISA and the mAbs were obtained. Immunohistochemistry was performed to detect the NPMc+ in bone marrow smears from 10 AML patients with NPM-mA. The results showed that the pET-32a-NPM-mA vector was successfully constructed and the NPM-mA recombinant protein was used to immunize the mice. Two positive clones (2G3 and 3F9) were selected. The mAbs against NPM-mA were raised, but did cross-react with wild type NPM1. The mAbs can be used to detect the cytoplasmic dislocation of NPM1 in all AMLs carrying NPM-mA. Our results show that anti-NPM-mA mAbs were produced. Though they would cross-react with wild type NPM1, the mAbs may still have potential in the detection of NPMc+AMLs.

Keywords: acute leukemia, nucleophosmin mutants, recombinant protein, monoclonal antibody

Citation styles

APA

Tan, S., Zhang, L., Zhong, X.M., Yang, Z.L., Zhao, L.Y., Gao, Y.J., Shao, H.Y., Qin, F.X., Chen, X.C., Zhang, H.J., Chen, H., Wang, L. (2011). Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia. International Journal of Medical Sciences, 8(4), 309-314. https://doi.org/10.7150/ijms.8.309.

ACS

Tan, S.; Zhang, L.; Zhong, X.M.; Yang, Z.L.; Zhao, L.Y.; Gao, Y.J.; Shao, H.Y.; Qin, F.X.; Chen, X.C.; Zhang, H.J.; Chen, H.; Wang, L. Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia. Int. J. Med. Sci. 2011, 8 (4), 309-314. DOI: 10.7150/ijms.8.309.

NLM

CSE

Tan S, Zhang L, Zhong XM, Yang ZL, Zhao LY, Gao YJ, Shao HY, Qin FX, Chen XC, Zhang HJ, Chen H, Wang L. 2011. Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia. Int J Med Sci. 8(4):309-314.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.